Abstract 4423: XMT-2056, a HER2-targeted STING agonist antibody-drug conjugate, exhibits ADCC function that synergizes with STING pathway activation and contributes to anti-tumor responses
Authors: Jahna Soomer-James, Marc Damelin, Naniye Malli
Published: 2023-06-09
DOI:
10.1158/1538-7445.am2023-4423
Source:
Full article
Abstract
Abstract